Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS

Longer-term safety of B-cell therapies in MS

[@demoskunk]

Very interesting. Since Ocrevus is the only dmt currently available for PPMS, I'll have to continue taking my chances with it. Hopefully the BTK inhibitors get FDA approval soon.

[@ernietollar407]

Ocrevus didn't help my PPMS so I'm in Mexico for HSCT in 5 days (a treatment which is effective in rebooting the faulty immune system of many with MS with cyclophosphide. Rituxan is used after the chemo.)

[@yasminsoliman9160]

HSCT is not beneficial in PPMS, unfortunate